Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06682364 · ClinicalTrials.gov registry record · NA

Opioid Use and Criminal Justice: Intervening to Improve the Outcomes of Women

A NA study of Opioid Use Disorder, sponsored by Abenaa Jones, Ph.D..

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06682364: Recruiting NA study of Opioid Use Disorder, sponsored by Abenaa Jones, Ph.D..

NCT06682364 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Abenaa Jones, Ph.D.. The registered enrollment target is 50 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06682364, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Abenaa Jones, Ph.D..

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Opioid-related overdose deaths and incarceration rates have skyrocketed and have disproportionately affected women. Despite having a higher burden of substance use disorders and HIV/AIDS than criminal justice-involved (CJI) men, CJI women are less likely to have access to substance use and HIV treatment. The planned research aims to improve how women in the criminal justice system connect to and stay in drug treatment. This will be done by creating and putting into practice a well-researched program specifically designed for women, considering their experiences with trauma. The program incorporates several best practices in substance use treatment such as the use of Certified Peer Recovery Specialists (CRS) as needed social support, assisting women who do not have stable housing in finding housing, overdose response training, and reducing known barriers to women by assisting with transportation and childcare. In addition, half of the women will be randomly selected to participate in a 12-session trauma support group led by CRS which uses the evidence-based curriculum, Beyond Trauma, which was specifically designed for women who use drugs. The aforementioned components are rarely offered in tandem with substance use treatment, and as such, this research is assessing if having this comprehensive program is linked with better substance use and social outcomes. The overall goal is to reduce the problem of opioid addiction and overdoses among women who have recently been involved in the criminal justice system and to reduce the barriers to opioid addiction treatment.

Primary Outcome

We will assess the feasibility of this pilot study by assessing the number of participants recruited and retained for the entire six-month duration of the intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Trauma-informed case management for women who use drugs
  • BEHAVIORAL CRS Only Intervention

Study Locations (1)

Pennsylvania

  • Recovery, Advocacy, Service, and Empowerment (RASE) - Harrisburg

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-11-13
Est. Completion 2025-12-01
Phase NA
Abenaa Jones, Ph.D.

1 total trials

What NCT06682364 shows while recruiting

NCT06682364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Trauma-informed case management for women who use drugs is the first listed.

NCT06682364 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06682364 about?

NCT06682364 is a clinical study titled "Opioid Use and Criminal Justice: Intervening to Improve the Outcomes of Women". Opioid-related overdose deaths and incarceration rates have skyrocketed and have disproportionately affected women. Despite having a higher burden of substance use disorders and HIV/AIDS than criminal justice-involved (CJI) men, CJI women are less likely to have access to substance use and HIV treat...

What is the current status of trial NCT06682364?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-11-13. Estimated completion is 2025-12-01.

What conditions does trial NCT06682364 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT06682364?

The interventions under investigation include: Trauma-informed case management for women who use drugs (BEHAVIORAL), CRS Only Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06682364?

This trial is sponsored by Abenaa Jones, Ph.D., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06682364 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06682364's enrollment target sits among peer trials

50 172nd of 257 higher than 80 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06682364, the US trial registry maintained by the National Library of Medicine. NCT06682364 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.